Alchemab Therapeutics unveils Alzheimer's candidate ATLX-1088 targeting CD33 at the Antibody Industrial Symposium
/PRNewswire/ -- Alchemab Therapeutics, an antibody discovery company identifying naturally occurring antibodies from individuals resilient to disease, today...